Kemp Dolliver

Stock Analyst at Brookline Capital

(0)
# 5194
Out of 5,380 analysts
24
Total ratings
Success rate
Average return
18 Stocks
Name Action PT Current % Upside Ratings Updated
YMAB Y-mAbs Therapeutics
Initiates Coverage On: Buy
17
5.17 228.82% 1 Dec 5, 2024
EYEN Eyenovia
Downgrades: Hold
n/a
n/a n/a 2 Nov 15, 2024
VRCA Verrica Pharmaceutic...
Downgrades: Hold
n/a
n/a n/a 2 Oct 2, 2024
ONCT Oncternal Therapeuti...
Downgrades: Hold
n/a
n/a n/a 3 Sep 12, 2024
IBIO iBio
Initiates Coverage On: Buy
4
0.73 393.15% 1 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
36
2.67 1248.31% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Mar 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
32
1.77 1674.01% 1 Jan 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
27 13
n/a n/a 1 Dec 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
81.04 23.4% 1 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
57
2 2750% 2 Oct 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
5
1.01 345.54% 1 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
25
2.79 796.06% 1 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
5.49 241.53% 1 Jan 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
8
0.74 981.08% 1 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.99 470.71% 1 Feb 2, 2022